熱門資訊> 正文
Avenue Therapeutics申请出售142万股股票
2024-05-07 03:14
- Avenue Therapeutics (NASDAQ:ATXI) has filed a prospectus related to the resale of 1.42M shares of common stock.
- The shares are set to be issued in three tranches, comprised of 689,680 series C warrant shares, 689,680 series D warrant shares, and 41,381 placement agent warrant shares.
- The preliminary prospectus is not an offer to sell the securities.
- FORM S-3
More on Avenue Therapeutics
- Avenue Therapeutics drops 9% on 1-for-75 reverse split
- Avenue Therapeutics granted extension for Nasdaq compliance
- Seeking Alpha’s Quant Rating on Avenue Therapeutics
- Historical earnings data for Avenue Therapeutics
- Financial information for Avenue Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
